EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic effects of amiodarone experimental and clinical observation relative to serum and tissue drug concentrations


, : Electrophysiologic effects of amiodarone experimental and clinical observation relative to serum and tissue drug concentrations. American Heart Journal 108(4 PART 1): 890-898

Oral amiodarone is a potent antiarrhythmic agent with a slow onset of action. Its electrophysiologic properties following chronic administration are well known, but its acute electrophysiological actions are poorly defined. The objectives of the present study were to correlate the electrophysiologic actions of i.v. amiodarone in humans with the acute and chronic effects of the drug relative to plasma and tissue concentrations of the drug. In humans (n = 10), 5 mg/kg i.v. amiodarone (serum concentration 6.50 .+-. 3.34 .mu.g/ml at 10 min, 2.13 .+-. 0.71 .mu.g/ml at 20 min, n = 7) increased the AH interval by 16.4% (P < 0.005), the antegrade effective refractory period (ERP) of the atrioventricular (AV) node by 14.4% (P < 0.025), and the functional refractory period (FRP) of the AV node of 15.5% (P < 0.005%). The ERP or FRP of the atrium of the right ventricle was not significantly changed; there was no effect on the HV interval or the QT and R-R intervals of the ECG. In rabbits (n = 11) given 10 mg/kg i.v. amiodarone (mean .+-. SD serum concentration 0.49 .+-. 0.17 .mu.g/ml; mean myocardial concentration 7.0 .+-. 1.9 .mu.g/gm, n = 3), there were no significant effects on the ECG intervals. In isolated rabbit sinoatrial (SA) node, atria, and AV node (3 preparations) superfused with 5 x 10-6 M amiodarone (3.41 .mu.g/ml), there was no effect on the action potential duration (APD) or other parameters of the transmembrane potential. Rabbits chronically pretreated with amiodarone (20 mg/kg i.p.) for 3 wk had serum drug concentrations of 0.98 .+-. 0.52 .mu.g/ml (n = 4) and myocardial levels of 11.52 .+-. 7.2 .mu.g/gm at 3 wk and 0.50 .+-. 0.18 .mu.g/ml and 14.8 .+-. 6.4 .mu.g/gm, respectively, at 6 wk. Compared to the values in control series, the spontaneous cycle length of the SA node was prolonged by 24% (P < 0.05) at 3 wk and 35.5% (P < 0.01) at 6 wk. The Vmax was affected in none of the tissues but APD was significantly lengthened in all. In atria the APD was increased by 27.6% (P < 0.01) at 3 wk and 32.8% (P < 0.01) at 6 wk; in ventricular muscle the corresponding values were 11.0% (P < 0.05) and 25.3% (P < 0.01). Major differences were indicated between the chronic and acute electrophysiologic effects of amiodarone, difference which are relevant to the interpretation Of the antiarrhythmic actions of the drug following i.v. and oral administration.

Accession: 005349286

PMID: 6485999

DOI: 10.1016/0002-8703(84)90451-4

Download PDF Full Text: Electrophysiologic effects of amiodarone experimental and clinical observation relative to serum and tissue drug concentrations


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Kamiya, K.; Kannan, R.; Matin-Asgari, A.; Singh, B.N., 1989: Electrophysiologic effects of flecainide relative to serum and tissue concentrations in rabbits after chronic drug administration. The effects of chronic treatment with flecainide on the cellular electrophysiology and the relationship of the electrophysiologic effects to serum and myocardial flecainide concentrations were determined in rabbit ventricular myocardium. Two group...

Singh B.N., 1988: Electrophysiologic effects of flecainide relative to serum and tissue concentrations in rabbit following chronic administration. Japanese Circulation Journal: 800

Tao, G.S.; Zhao, C.Y.; Wang, X.S., 1986: Combined amiodarone and quinidine treatment in refractory tachyarrhythmias; clinical observation and experimental electrophysiologic study. Zhonghua Nei Ke Za Zhi 25(6): 335-7, 380-1

Borggrefe M.; Leibner M.; Breithardt G., 1986: Clinical electrophysiologic effects of combining class i antiarrhythmic agents with amiodarone in drug refractory tachycardia. American Heart Association Monograph (124): II-224

Venkatesh N.; Padbury J.F.; Singh B.N., 1986: Effects of amiodarone and deethylamiodarone on rabbit myocardial beta adrenoceptors and serum thyroid hormone absence of relationship to serum and myocardial drug concentrations. The antiadrenergic actions of amiodarone (Am) are well known but its effect and that of its metabolite, desethylamiodarone (DAm), on .beta.-receptor density (Bmax) and affinity (KD) are poorly defined. Thus, the acute and chronic effects of Am and...

Venkatesh, N.; Padbury, J.F.; Singh, B.N., 1986: Effects of amiodarone and desethylamiodarone on rabbit myocardial beta-adrenoceptors and serum thyroid hormones--absence of relationship to serum and myocardial drug concentrations. The antiadrenergic actions of amiodarone (Am) are well known but its effect and that of its metabolite, desethylamiodarone (DAm), on beta-receptor density (Bmax) and affinity (KD) are poorly defined. Thus, the acute and chronic effects of Am and D...

Greenberg M.L.; Lerman B.B.; Shipe J.R.; Kaiser D.L.; Dimarco J.P., 1987: Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects efficacy and toxicity. Because the value of monitoring amiodarone plasma concentrations remains undefined, this study was performed to evaluate its role during the management of patients receiving amiodarone. The early electrophysiologic effects of amiodarone were asses...

Scott, C.D.; Buss, D.; Routledge, P.A.; Morgan Hughes, N.J.; Dark, J.H.; Mccomb, J.M., 1993: Correlation of tissue levels of amiodarone with electrophysiologic effects. Circulation 88(4 PART 2): I447

Somani, P., 1989: Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies. Amiodarone is a unique class III antiarrhythmic drug with several unusual pharmacokinetic, pharmacodynamic, and toxicological actions which are quite distinct from those of the standard antiarrhythmic drugs. Extensive animal and clinical studies h...

Zipes, D.P.; Prystowsky, E.N.; Heger, J.J., 1984: Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. Interest in amiodarone has increased because of its remarkable efficacy as an antiarrhythmic agent. The purpose of this report is to review what is known about the electrophysiologic actions, hemodynamic effects, pharmacokinetics, alterations of t...